Neuphoria Therapeutics (NEUP) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Neuphoria Therapeutics (NEUP) over the last 3 years, with Q4 2025 value amounting to 0.47.
- Neuphoria Therapeutics' Asset Utilization Ratio rose 135304.91% to 0.47 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.47, marking a year-over-year increase of 135304.91%. This contributed to the annual value of 0.0 for FY2023, which is N/A changed from last year.
- Neuphoria Therapeutics' Asset Utilization Ratio amounted to 0.47 in Q4 2025, which was up 135304.91% from 0.56 recorded in Q3 2025.
- In the past 5 years, Neuphoria Therapeutics' Asset Utilization Ratio ranged from a high of 0.64 in Q1 2025 and a low of 0.01 during Q4 2021
- For the 3-year period, Neuphoria Therapeutics' Asset Utilization Ratio averaged around 0.37, with its median value being 0.5 (2025).
- Data for Neuphoria Therapeutics' Asset Utilization Ratio shows a peak YoY increase of 135304.91% (in 2025) and a maximum YoY decrease of 135304.91% (in 2025) over the last 5 years.
- Neuphoria Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then surged by 373.24% to 0.03 in 2024, then soared by 1353.05% to 0.47 in 2025.
- Its last three reported values are 0.47 in Q4 2025, 0.56 for Q3 2025, and 0.53 during Q2 2025.